Female infertility
Female-factor infertility can result from problems with ovulation, ovarian function, the fallopian tubes, uterus or other reproductive conditions. Evaluation focuses on identifying the factor most likely to limit conception while also assessing the other reproductive partner when applicable.
At a glance
Quick facts
- Major factors
- Ovulation, age, tubes, uterus and ovarian function
- Cycle clue
- Regular monthly cycles usually suggest ovulation
- Tubal tests
- HSG or ultrasound-based patency testing
- Ovarian reserve
- AMH or AFC can help predict response to stimulation
- Important limit
- AMH does not predict spontaneous pregnancy well
- Treatment
- Cause-directed care, IUI or IVF
Dr. Farida Sani
Fertility Physician · Clearview Hospital and Fertility
Reviewed for clinical accuracy, fertility context and patient-facing clarity.
Names & terminology
How this entity may be named or searched
- Female-factor infertility
- Infertility in which a female reproductive factor contributes to difficulty conceiving.
- Ovarian reserve
- The remaining quantity of oocytes; it is not the same as egg quality or a guarantee of pregnancy.
- Tubal patency
- Whether at least one fallopian tube is open enough for sperm and egg to meet.
- Ovulatory disorder
- A condition in which ovulation is absent, irregular or otherwise impaired.
Structured entity profile
Clinical profile
Overview
Female infertility describes infertility in which a factor involving the ovaries, ovulation, fallopian tubes, uterus or reproductive endocrine system contributes to difficulty conceiving. WHO notes that female causes include tubal disorders, uterine conditions such as fibroids, ovarian disorders such as PCOS and endocrine abnormalities. [1]
Female age is a central part of fertility counselling because the probability of spontaneous conception and assisted-reproduction outcomes change with age. A complete evaluation should still consider male factors in parallel rather than assuming that a female diagnosis explains the entire fertility problem. [2] [3]
Symptoms and warning signs
Many causes of female infertility have no obvious symptoms beyond delayed conception. Clues can include irregular or absent periods, pelvic pain, heavy or abnormal bleeding, a history of pelvic inflammatory disease or ectopic pregnancy, or previous pelvic surgery. Regular cycles do not exclude tubal, uterine or age-related fertility problems. [1] [2]
SYMPTOM MATRIX
Symptoms can suggest a cause, but many female factors are silent
The pattern of cycles and reproductive history guide testing more than symptoms alone.
- Difficulty conceiving
- No other symptoms
- Questions about age and ovarian reserve
- Need to assess ovulation and tubal patency
- Irregular or absent periods
- Pelvic pain or painful periods
- Previous PID or ectopic pregnancy
- Heavy or abnormal uterine bleeding
- Prior pelvic or ovarian surgery
- Age where further delay may reduce options
- Marked menstrual irregularity or amenorrhoea
- Known bilateral tubal disease
- Previous gonadotoxic treatment or major ovarian surgery
A known fertility-limiting condition is a reason to assess earlier rather than waiting automatically for the standard infertility interval.
Diagnosis
Assessment begins with reproductive history, menstrual pattern, pregnancy history, medical and surgical history, medications and age. NICE advises asking about cycle frequency and regularity and notes that regular monthly cycles make ovulation likely. Ovulation testing is targeted when the cycle pattern or history suggests dysfunction. [2]
Tubal patency can be assessed with hysterosalpingography (HSG) or ultrasound-based methods such as hysterosalpingo-contrast sonography where appropriate. Laparoscopy with dye is generally reserved for selected patients, especially when pelvic disease such as endometriosis or prior infection is suspected. AMH or antral follicle count can help estimate ovarian response to assisted conception, but NICE advises against using AMH to predict spontaneous pregnancy. [2] [3]
Diagnostic pathway
Separate ovulation, ovarian response and anatomy
A useful fertility work-up answers different questions rather than relying on a single “fertility test”.
Fertility assessment is usually most useful when relevant male and female factors are evaluated in parallel.
What ovarian reserve testing can and cannot tell you
Ovarian reserve describes the quantity of remaining oocytes and the expected response to ovarian stimulation. AMH and antral follicle count are useful in fertility treatment planning, but they should be interpreted alongside age and diagnosis. A low result does not by itself mean that spontaneous conception is impossible. [2] [3]
Ovarian-reserve tests such as AMH and antral follicle count can help with treatment planning and expected response, but they are interpreted together with age and the rest of the fertility assessment.
Treatment and management
Treatment is directed at the factor identified. Ovulatory disorders may be treated with cause-specific measures or ovulation induction; selected tubal or uterine conditions may be treated surgically; and assisted reproduction may be appropriate when anatomy, age, duration of infertility or previous treatment make it the better option. [1] [2]
IVF can bypass tubal disease and can also be used for other female-factor diagnoses. Treatment planning should consider age, ovarian response, semen factors, previous pregnancy history, risks of ovarian stimulation and the patient’s preferences about time and treatment burden. [2]
Treatment & care hub
Treat the limiting factor rather than the test result
A fertility plan should connect the diagnosis to a realistic route to conception.
Restore or induce ovulation when needed
Management depends on whether the cause is PCOS, hypothalamic dysfunction, hyperprolactinaemia or another disorder.
Treat uterine or tubal disease
Surgery can be useful for defined structural problems when benefit is expected.
Use IUI or IVF strategically
Choice depends on diagnosis, age, duration of infertility, semen factors and previous treatment.
Interpret ovarian reserve carefully
AMH and AFC help with stimulation planning but should not be presented as a simple fertility score.
Treatment is individualized according to diagnosis, age, reproductive goals and clinical context.
Age and timing of treatment
Age affects both the natural probability of pregnancy and outcomes of assisted reproduction. ASRM recommends starting evaluation sooner from age 35 and considering more immediate assessment over age 40 or when a known infertility-associated condition is present. Individual pathways and access rules vary by country. [3]
Evidence snapshot
Female infertility has many pathways, not one single test
The same symptom of delayed conception can reflect ovulatory, tubal, uterine, ovarian or mixed factors.
Common questions
Frequently asked questions
Ovulatory disorders, tubal disease, uterine conditions, endometriosis, ovarian dysfunction and age-related reproductive decline can all contribute.
Regular cycles usually suggest ovulation, but they do not rule out tubal, uterine, male-factor or age-related causes of infertility.
No. AMH is mainly useful for estimating ovarian response to stimulation and should not be used as a stand-alone predictor of spontaneous pregnancy.
HSG or ultrasound-based contrast testing are common first-line approaches, with laparoscopy reserved for selected situations.
No. The best treatment depends on the cause, age, duration of infertility, other partner factors and previous treatment.
Sources
- WHO — Infertility fact sheet, 28 November 2025
- NICE — Fertility problems: assessment and treatment (NG257) - investigation, 2026
- ASRM — Fertility evaluation of infertile women: a committee opinion, 2021
This article is based on trusted medical sources and has undergone clinician review. It is not a substitute for personalized medical advice.
Regular menstrual cycles do not completely exclude ovulatory dysfunction because sporadic anovulation can occur. The wider fertility evaluation still matters when pregnancy is not occurring.